Literature DB >> 14625027

Sex-dependent effects of delta 9-tetrahydrocannabinol on locomotor activity in mice.

Jenny L Wiley1.   

Abstract

Sex differences in the effects of several drugs of abuse have previously been demonstrated. The present study evaluated sex differences in the effects of acute and repeated dosing with Delta(9)-tetrahydrocannabinol on locomotor activity in male and female Swiss Webster (CFW) mice. Results showed that acute Delta(9)-tetrahydrocannibol (1-30 mg/kg) increased locomotor activity in female, but not in male, mice. Following 3 days of daily injections of 10 mg/kg Delta(9)-tetrahydrocannabinol, re-tests of the same doses of Delta(9)-tetrahydrocannabinol tested acutely showed that female mice continued to exhibit greater sensitivity to the stimulatory effects of Delta(9)-tetrahydrocannabinol than did male mice; however, higher doses were required to produce these increases, suggesting a modest degree of tolerance development. These results are consistent with those of previous studies in which cannabinoids were more potent at producing locomotor suppression and antinociception in female than in male rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625027     DOI: 10.1016/j.neulet.2003.08.050

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

Review 1.  Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?

Authors:  Rebecca M Craft; Julie A Marusich; Jenny L Wiley
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

2.  Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats.

Authors:  Charlotte E Farquhar; Christopher S Breivogel; Thomas F Gamage; Elaine A Gay; Brian F Thomas; Rebecca M Craft; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2018-10-25       Impact factor: 4.492

3.  Receptor subtypes and signal transduction mechanisms contributing to the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis.

Authors:  Neal Washburn; Amanda Borgquist; Kate Wang; Garrett S Jeffery; Martin J Kelly; Edward J Wagner
Journal:  Neuroendocrinology       Date:  2012-08-28       Impact factor: 4.914

Review 4.  Physical activity and the endocannabinoid system: an overview.

Authors:  Mirko Tantimonaco; Roberta Ceci; Stefania Sabatini; Maria Valeria Catani; Antonello Rossi; Valeria Gasperi; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2014-02-14       Impact factor: 9.261

5.  Investigation of sex-dependent effects of cannabis in daily cannabis smokers.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

6.  Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test.

Authors:  Rebecca A LaFleur; Ronald P Wilson; Daniel J Morgan; Angela N Henderson-Redmond
Journal:  Neuroreport       Date:  2018-04-11       Impact factor: 1.837

Review 7.  Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.

Authors:  Ziva D Cooper; Rebecca M Craft
Journal:  Neuropsychopharmacology       Date:  2017-07-17       Impact factor: 7.853

Review 8.  Framework for sex differences in adolescent neurobiology: a focus on cannabinoids.

Authors:  Maria-Paz Viveros; Eva M Marco; Meritxell López-Gallardo; Luis Miguel Garcia-Segura; Edward J Wagner
Journal:  Neurosci Biobehav Rev       Date:  2010-09-30       Impact factor: 8.989

9.  Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats.

Authors:  Jacques D Nguyen; Yanabel Grant; Tony M Kerr; Arnold Gutierrez; Maury Cole; Michael A Taffe
Journal:  Pharmacol Biochem Behav       Date:  2018-07-19       Impact factor: 3.533

Review 10.  Sex differences in the cannabinoid regulation of energy homeostasis.

Authors:  Borzoo Farhang; Shanna Diaz; Stephanie L Tang; Edward J Wagner
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.